Pia Renaudin - Senzime AB Chief Officer
| SEZI Stock | SEK 5.80 0.13 2.29% |
Executive
Ms. Pia Renaudin was appointed Chief Executive Officer of Senzime AB effective as of February 7, 2019. She has over 20 years of leadership experience from international sales and marketing roles at companies such as AstraZeneca and Gilead Sciences, and is General Manager Nordics at Stryker, a medical device company. She holds an MBA from the Gothenburg University and a degree from INSEAD. since 2019.
| Age | 56 |
| Tenure | 5 years |
| Professional Marks | MBA |
| Phone | 46 18 51 56 40 |
| Web | https://senzime.com |
Senzime AB Management Efficiency
The company has return on total asset (ROA) of (0.2949) % which means that it has lost $0.2949 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6434) %, meaning that it generated substantial loss on money invested by shareholders. Senzime AB's management efficiency ratios could be used to measure how well Senzime AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | EXECUTIVE Age | ||
| Jesper Lind | Orexo AB | 63 | |
| Andres McAllister | BioInvent International AB | 67 | |
| Steve Kim | Anoto Group AB | 55 | |
| Lena Wange | Orexo AB | N/A | |
Management Performance
| Return On Equity | -0.64 | |||
| Return On Asset | -0.29 |
Senzime AB Leadership Team
Elected by the shareholders, the Senzime AB's board of directors comprises two types of representatives: Senzime AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Senzime. The board's role is to monitor Senzime AB's management team and ensure that shareholders' interests are well served. Senzime AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Senzime AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anders Selin, VP Sales | ||
| Johanna Tulkki, COO CTO | ||
| Rianne Waninge, Application Scientist | ||
| Pia Renaudin, Chief Officer | ||
| Anders Jacobson, Chief Technical Officer | ||
| Catrin Molund, Business Development Director | ||
| Slavoljub Grujicic, Chief Officer |
Senzime Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Senzime AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.64 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (8.35) % | |||
| Current Valuation | 771.13 M | |||
| Shares Outstanding | 69.88 M | |||
| Shares Owned By Insiders | 43.52 % | |||
| Shares Owned By Institutions | 17.18 % | |||
| Price To Earning | (25.28) X | |||
| Price To Book | 2.70 X | |||
| Price To Sales | 60.95 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Senzime Stock Analysis
When running Senzime AB's price analysis, check to measure Senzime AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senzime AB is operating at the current time. Most of Senzime AB's value examination focuses on studying past and present price action to predict the probability of Senzime AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senzime AB's price. Additionally, you may evaluate how the addition of Senzime AB to your portfolios can decrease your overall portfolio volatility.